Results 121 to 130 of about 49,296 (252)

Spontaneous Ischemic Cholecystitis in a Patient with Hereditary Hemorrhagic Telangiectasia (HHT) [PDF]

Romain L’Huillier, Alexandre Garnaud, Olivier Monneuse   +2 more
openalex   +1 more source

Candida Albicans and Escherichia Coli Superinfection in Emphysematous Pyelonephritis: A Case Report of A Challenging Presentation and Management

Clinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT Emphysematous pyelonephritis is a rare, life‐threatening infection of the kidney characterized by necrosis and gas formation within the renal parenchyma, collecting system, and perinephric tissue. It commonly occurs in patients with poorly controlled type 2 diabetes mellitus (T2DM) and in those with obstructive nephropathy.
Daniel P. Mujuni, Abid M. Sadiq, Kajiru G. Kilonzo, Raya S. Hamad, Abel Mwanga, Elphius J. Asila, Donald D. Lema, Elichilia R. Shao, Elifuraha W. Mkwizu, Nyasatu G. Chamba   +9 more
wiley   +1 more source

Acute Cholecystitis [PDF]

JAMA, 2022
openaire   +2 more sources

Percutaneous Drainage of a Post‐ERCP Liver Abscess: Successful Management of a Rare Complication—A Case Report

Clinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT Endoscopic retrograde cholangiopancreatography (ERCP) with sphincterotomy is an established treatment for choledocholithiasis but may rarely lead to pyogenic liver abscess (PLA). We report the case of a 72‐year‐old woman with a history of biliary stenting who presented with jaundice and cholestasis.
Yavor Asenov, Georgi Jelev, Ivan Vasilev, Boris Kunev, Marin Parunev, Nikolay Penkov, Teophil Sedloev, Ivan Dimitrov   +7 more
wiley   +1 more source

Tirzepatide and Cardiovascular Outcomes: A Narrative Review of Mechanisms, Efficacy and Implications for Heart Failure Management

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 1, January 2026.
Integrated framework for tirzepatide in HFpEF management. Through metabolic, haemodynamic, structural and anti‐inflammatory pathways, tirzepatide modifies the disease trajectory of HFpEF, leading to improvements in symptoms, functional capacity and reduction in HF events.
Hamza A. Abdul‐Hafez, Ameer Awashra, Sosana Bdir, Sarah Saife, Qasem Salah, Mohammed Barbarawi, Thabet Swaileh, Ahmed Emara, Mohamed S. Elgendy, Abdalhakim Shubietah   +9 more
wiley   +1 more source

Gemcitabine, Carboplatin, Dexamethasone, and Rituximab Versus High‐Dose Cytarabine‐Based Chemotherapy as Second‐Line Treatments for Relapsed or Refractory Diffuse Large B‐Cell Lymphoma

Hematological Oncology, Volume 44, Issue 1, January 2026.
ABSTRACT The optimal second‐line chemotherapy regimen for relapsed or refractory diffuse large B‐cell lymphoma (R/R DLBCL) remains uncertain. We retrospectively compared efficacy and safety between gemcitabine, carboplatin, dexamethasone, and rituximab (GCD‐R) and cyclophosphamide, high‐dose cytarabine, dexamethasone, etoposide, and rituximab (CHASER ...
Yoshikazu Ikoma, Nobuhiko Nakamura, Junichi Kitagawa, Naoki Hayase, Eri Takada, Takuro Matsumoto, Yuhei Shibata, Hiroshi Nakamura, Kei Fujita, Shin Lee, Tetsuji Morishita, Nobuhiro Kanemura, Senji Kasahara, Hideko Goto, Kenji Fukuno, Takeshi Hara, Michio Sawada, Hisashi Tsurumi, Masahito Shimizu   +18 more
wiley   +1 more source

Spontaneous cholecystocutaneous fistula secondary to xanthogranulomatous cholecystitis: a case report [PDF]

, 2022
Abdullah Almayouf, Hassan M. Ahmed, Adel A. Alzahrani, Abdulrahman H. Alashkar   +3 more
openalex   +1 more source

Rebalancing Hemostasis: Fitusiran as a First‐in‐Class RNAi Therapy in Hemophilia A and B

Health Science Reports, Volume 9, Issue 1, January 2026.
ABSTRACT Background and Aims Fitusiran is a first‐in‐class RNA interference (RNAi) therapy that lowers antithrombin (AT) to rebalance hemostasis in people with Hemophilia A or B, with or without inhibitors. Its recent FDA approval marks a major shift toward factor‐independent prophylaxis.
Raza Ur Rehman, Rida Fatima, Aymar Akilimali   +2 more
wiley   +1 more source

MICROFLORA OF A ABDOMINAL CAVITY OF PATIENTS WITH A ACUTE AND CHRONIC CHOLECYSTITIS

, 2005
Benjamin Osipov, V. A. Osipov
openalex   +2 more sources

Differentiation of Gallbladder Adenomyomatosis and Polyps in a Western Cohort: Prevalence, Ultrasound Characteristics, and Diagnostic Challenges

JGH Open, Volume 10, Issue 1, January 2026.
ABSTRACT Background Gallbladder adenomyomatosis and polyps are common benign lesions that can mimic malignancy on imaging, often leading to unnecessary cholecystectomy. Despite frequent sonographic detection, the prevalence of adenomyomatosis in living cohorts remains poorly defined.
Marie Neumann, Michael Kallenbach, Ulrike Morgera, Andrea Cariati, Lars Morawietz, Frank Jacobsen, Frank Dubois, Sebastian Herberger, Falko Hanisch, Slim Khouja, Wolfram Wermke, Yvonne Dörffel   +11 more
wiley   +1 more source